IDEX(IEX)
Search documents
IDEX(IEX) - 2022 Q2 - Quarterly Report
2022-07-27 17:51
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10235 IDEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 36-3555336 (State or other jurisdicti ...
IDEX(IEX) - 2022 Q2 - Earnings Call Presentation
2022-07-27 17:37
Second Quarter 2022 Earnings July 27, 2022 Fluid & Metering Health & Science Fire & Safety / Diversified Trusted Solutions, Improving Lives™ Agenda IDEX Business Overview Q2 2022 Financial Performance Segment Performance 2022 Guidance Summary Q&A 2 IDEX Proprietary & Confidential Replay Information • International: 201.612.7415 • Dial toll–free: 877.660.6853 • Conference ID: #13724804 • Log on to: www.idexcorp.com 3 IDEX Proprietary & Confidential Cautionary Statement Cautionary Statement Under the Private ...
IDEX(IEX) - 2022 Q1 - Earnings Call Transcript
2022-04-27 21:02
IDEX Corporation (NYSE:IEX) Q1 2022 Earnings Conference Call April 27, 2022 10:30 AM ET Company Participants Allison Lausas - Vice President and Chief Accounting Officer Eric Ashleman - Chief Executive Officer and President William Grogan - Senior Vice President and Chief Financial Officer Conference Call Participants Michael Halloran - Robert W. Baird & Co. Nathan Jones - Stifel Financial Corp. Deane Dray - RBC Capital Markets Allison Poliniak - Wells Fargo Securities LLC Joseph Giordano - Cowen Inc. Vlad ...
IDEX(IEX) - 2022 Q1 - Quarterly Report
2022-04-27 16:58
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents Commission file number 1-10235 IDEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 36-3555336 (State or other jurisdict ...
IDEX Corporation (IEX) Presents at the Citi Global Industrial Tech and Mobility Conference - Slideshow
2022-03-06 15:13
IDEX Proprietary & Confidential Trusted Solutions, Improving Lives™ Citi Global Industrial Tech and Mobility Conference February 22, 2022 Click to edit Master title style Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures SAFE HARBOR STATEMENT This presentation and discussion will include "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's ...
IDEX(IEX) - 2021 Q4 - Annual Report
2022-02-24 18:47
For the transition period from to Commission file number 1-10235 IDEX CORPORATION (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) 3100 San ...
IDEX(IEX) - 2021 Q4 - Earnings Call Presentation
2022-02-03 05:34
Financial Performance - IDEX reported record financial results with strong rebound in demand and margin expansion despite inflationary environment[6] - Q4 2021 sales reached $715 million, a 16% increase, with 11% organic growth[10,31] - Full year 2021 sales were $2765 million, an 18% increase, with 12% organic growth[10,31] - Adjusted earnings per share for Q4 2021 were $171, compared to $137 in Q4 2020[10,37] - Adjusted earnings per share for full year 2021 were $687, compared to $519 in full year 2020[10,37] - Free cash flow for full year 2021 was $493 million, a decrease of 5%[10] Segment Performance - Fluid & Metering Technology (FMT) full year 2021 revenue was $999 million, representing 36% of total revenue[8] - Health & Science Technology (HST) full year 2021 revenue was $1122 million, representing 41% of total revenue[8] - Fire & Safety/Diversified Products (FSDP) full year 2021 revenue was $648 million, representing 23% of total revenue[8] 2022 Guidance - The company anticipates full year 2022 reported revenue growth of 6-9% and organic revenue growth of 5-8%[15] - Full year 2022 adjusted EPS is estimated to be in the range of $733-$763[15]
IDEX(IEX) - 2021 Q4 - Earnings Call Transcript
2022-02-02 23:07
IDEX Corporation (NYSE:IEX) Q4 2021 Earnings Conference Call February 2, 2022 10:30 AM ET Company Participants Eric Ashleman – Chief Executive Officer Allison Lausas – Vice President and Chief Accounting Officer Bill Grogan – Chief Financial Officer Conference Call Participants Allison Poliniak – Wells Fargo Mike Halloran – Robert W. Baird Deane Dray – RBC Capital Markets Rob Wertheimer – Melius Research Nathan Jones – Stifel Matt Summerville – D.A. Davidson Andrew Buscaglia – Birenberg Connor Lynagh – Morg ...
IDEX(IEX) - 2021 Q3 - Earnings Call Transcript
2021-10-27 21:17
IDEX Corporation (NYSE:IEX) Q3 2021 Results Earnings Conference Call October 27, 2021 10:30 AM ET Company Participants Allison Lausas - Vice President and Chief Accounting Officer Eric Ashleman - CEO Bill Grogan - CFO Conference Call Participants Nathan Jones - Stifel Deane Dray - RBC Capital Markets Mike Halloran - Robert W. Baird Matt Summerville - D.A. Davidson Allison Poliniak - Wells Fargo Rob Wertheimer - Melius Research Vlad Bystricky - Citigroup Operator Greetings. And welcome to the IDEX Corporatio ...
IDEX(IEX) - 2021 Q3 - Quarterly Report
2021-10-27 15:53
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10235 IDEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 36-3555336 (State or other juris ...